SARS-CoV-2

The Delhi High Court on ...

The company has given conditions to the centre for supply of its vaccine, including not undertaking bridging trials and waiver of indemnity. But experts warn against removing all regulatory oversight.

The petitioners referred to a report published on April 15 by medical journal Lancet, which revealed that there was strong evidence that SARS-CoV-2 was spreading by airborne transmission.

There has been much debate about the pros and cons of the therapy and trials have shown that it improves symptoms like difficulty in breathing and fatigue. But the decision is best left to the physician.

Various codes of conduct prescribed in the context of SARS-CoV-2 remind one of Manusmriti, which lays down the rules for the sacraments, the study of the Vedas and other rites

Hours after having advise...